Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Mar 16, 2025; 17(3): 99540
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.99540
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.99540
Figure 3 A subgroup analyses forest plot of the risk factors for metabolic dysfunction-associated steatotic liver disease associated with metachronous gastric cancer.
MASLD: Metabolic dysfunction-associated steatotic liver disease; PD: Poorly differentiated; WD: Well differentiated; MD: Moderately differentiated; HR: Hazard ratio; CI: Confidence interval; H. pylori: Helicobacter pylori.
- Citation: Xiang Y, Yuan Y, Wang ZY, Zhu YM, Li WY, Ye QG, Wang YN, Sun Q, Ding XW, Longi F, Tang DH, Xu GF. Comorbidities related to metachronous recurrence for early gastric cancer in elderly patients. World J Gastrointest Endosc 2025; 17(3): 99540
- URL: https://www.wjgnet.com/1948-5190/full/v17/i3/99540.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i3.99540